ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04217	Necroptosis	28/171	178/7206	6.2119493298e-16
ko04621	NOD-like receptor signaling pathway	25/171	157/7206	1.95010816158e-14
ko04060	Cytokine-cytokine receptor interaction	27/171	191/7206	3.33043968659e-14
ko05340	Primary immunodeficiency	13/171	30/7206	4.04255172398e-14
ko05162	Measles	21/171	120/7206	4.12828711795e-13
ko05164	Influenza A	24/171	167/7206	7.0087064444e-13
ko05168	Herpes simplex infection	24/171	182/7206	4.74277637326e-12
ko04612	Antigen processing and presentation	16/171	77/7206	1.9475237596e-11
ko04630	Jak-STAT signaling pathway	20/171	132/7206	2.48062205531e-11
ko05321	Inflammatory bowel disease (IBD)	14/171	56/7206	2.57220904618e-11
ko04659	Th17 cell differentiation	18/171	106/7206	3.67928859561e-11
ko05145	Toxoplasmosis	19/171	126/7206	8.8002668797e-11
ko04650	Natural killer cell mediated cytotoxicity	16/171	97/7206	7.48659176998e-10
ko05330	Allograft rejection	9/171	24/7206	1.86251749731e-09
ko04380	Osteoclast differentiation	18/171	134/7206	1.9688806874e-09
ko04658	Th1 and Th2 cell differentiation	15/171	96/7206	5.67387637375e-09
ko05320	Autoimmune thyroid disease	9/171	29/7206	1.28805410571e-08
ko05152	Tuberculosis	20/171	187/7206	1.35703056202e-08
ko05140	Leishmaniasis	13/171	75/7206	1.6895989695e-08
ko04064	NF-kappa B signaling pathway	14/171	96/7206	4.64750581374e-08
ko05332	Graft-versus-host disease	7/171	18/7206	9.57241000439e-08
ko04620	Toll-like receptor signaling pathway	13/171	100/7206	5.66669426703e-07
ko05167	Kaposi's sarcoma-associated herpesvirus infection	17/171	191/7206	2.43676000183e-06
ko05161	Hepatitis B	16/171	173/7206	2.96492999648e-06
ko03050	Proteasome	9/171	54/7206	4.10678324131e-06
ko04940	Type I diabetes mellitus	7/171	32/7206	7.64536516593e-06
ko04640	Hematopoietic cell lineage	9/171	64/7206	1.73501176197e-05
ko04062	Chemokine signaling pathway	16/171	201/7206	2.0315036775e-05
ko04660	T cell receptor signaling pathway	12/171	124/7206	3.43658185493e-05
ko05310	Asthma	5/171	17/7206	3.48499712122e-05
ko05133	Pertussis	10/171	87/7206	3.59629759958e-05
ko05160	Hepatitis C	13/171	153/7206	6.39670435605e-05
ko05144	Malaria	7/171	45/7206	7.94824990306e-05
ko04622	RIG-I-like receptor signaling pathway	8/171	62/7206	9.68323316397e-05
ko04672	Intestinal immune network for IgA production	6/171	37/7206	0.000206429348414
ko05142	Chagas disease (American trypanosomiasis)	11/171	130/7206	0.000245670519136
ko04145	Phagosome	12/171	162/7206	0.000444154889155
ko04210	Apoptosis	12/171	180/7206	0.00113458556759
ko05323	Rheumatoid arthritis	8/171	89/7206	0.00117543144886
ko05169	Epstein-Barr virus infection	13/171	206/7206	0.0011787461617
ko05150	Staphylococcus aureus infection	5/171	36/7206	0.0014740651736
ko05416	Viral myocarditis	6/171	55/7206	0.00180971891906
ko04668	TNF signaling pathway	9/171	120/7206	0.00211786703173
ko04623	Cytosolic DNA-sensing pathway	5/171	41/7206	0.00266350853632
ko04514	Cell adhesion molecules (CAMs)	9/171	130/7206	0.00364552873466
ko04662	B cell receptor signaling pathway	7/171	88/7206	0.00473704998397
ko05143	African trypanosomiasis	4/171	32/7206	0.00655442057911
ko04080	Neuroactive ligand-receptor interaction	3/171	423/7206	0.0192550827477
ko05166	HTLV-I infection	13/171	292/7206	0.0277421740727
ko05146	Amoebiasis	6/171	99/7206	0.0298955776318
ko04664	Fc epsilon RI signaling pathway	5/171	77/7206	0.0356150336557
ko05131	Shigellosis	5/171	82/7206	0.0448130606487
ko04530	Tight junction	1/171	228/7206	0.0452777966768